Artera
Enhancing oncology precision with AI-driven, rapid cancer assessments.
Key Takeaways
- What it is
- Enhancing oncology precision with AI-driven, rapid cancer assessments.
- Best for
- AI-Driven Predictive Models
- Prognostic Assessments
- Non-Invasive Technology
- Rating
- 4.7/5
What is Artera?
Artera is at the forefront of integrating artificial intelligence (AI) into the realm of oncology, specifically focusing on prostate cancer. This innovative tool leverages multimodal AI (MMAI) to enhance the precision of cancer therapy by providing predictive and prognostic assessments that guide treatment decisions. Designed primarily for clinicians and healthcare providers, Artera simplifies the complex decision-making process in cancer treatment by offering a data-driven, personalized approach to each patient's care.
Artera stands out in the oncology field with its unique multimodal AI approach that not only predicts outcomes but also preserves the integrity of biological samples. Its inclusion in the NCCN Clinical Practice Guidelines for Prostate Cancer underscores its recognized efficacy and innovative impact on cancer care.
Artera excels in delivering cutting-edge, AI-driven insights for prostate cancer treatment, making it an indispensable tool for oncologists and healthcare providers. Its ability to provide rapid, accurate, and non-invasive prognostic and predictive assessments offers an unmatched advantage in personalized cancer care.
Who is Using Artera?
Oncologists
Utilizing the tool to refine treatment strategies based on individual patient data.
Research Institutions
Employing the tool to study cancer treatments and their outcomes.
Healthcare Policy Makers
Leveraging the tool to understand and improve cancer care standards.
Educational Facilities
Using the tool for academic purposes, training the next generation of oncologists.
Uncommon Use Cases
Utilized by health data analysts for big data research; adopted by biotech companies for developing new cancer therapies.
Key Features
Rating Breakdown
Pricing Plans
Contact for Quote
- Pricing details are tailored to the institution's needs and usage scale
Artera Use Cases
Therapy-benefit prediction
Use multimodal AI analysis to help predict whether a patient is likely to benefit from specific therapies.
Outcome: More personalized treatment discussions.
Active-surveillance decision support
Use the test to help inform decisions about active surveillance in localized prostate cancer.
Outcome: Additional risk information for clinical decision-making.
Long-term prognostication
Assess long-term outcomes using biopsy-image and clinical data analysis.
Outcome: A supplemental prognostic assessment.
Post-prostatectomy treatment planning
Use the test when PSA rises after surgery and additional treatment is under consideration.
Outcome: Additional information for treatment planning.
Workflow Ideas with Artera
Order and receive an ArteraAI prostate report
- 1Clinician orders the ArteraAI Prostate Test
- 2The original biopsy slide and clinical information are analyzed
- 3The clinician receives the report through the portal or by fax
Use ArteraAI in treatment planning
- 1Review the patient’s localized prostate-cancer diagnosis
- 2Use the test to assess predicted therapy benefit and prognosis
- 3Discuss treatment or active-surveillance options with the patient
How Artera fits into your stack
Digital Pathology Platforms
Seamlessly integrates with existing digital pathology infrastructures.
Clinical Data Systems
Compatible with various clinical data formats, enhancing data analysis capabilities.
Healthcare Networks
Easily adopted across different healthcare systems due to its adaptable technology.
Educational Tools
Provides resources for training and education in medical institutions.
Pros
- +Enhanced Decision-Making: Empowers clinicians with detailed, data-backed insights for personalized treatment plans.
- +Increased Efficiency: Significantly reduces the time to results, enabling faster initiation of tailored therapies.
- +High Precision: Offers superior predictive and prognostic capabilities compared to traditional methods.
- +Patient-Centric Approach: Supports shared decision-making between clinicians and patients, fostering a collaborative care environment.
Cons
- −Specialized Application: Primarily focuses on prostate cancer, which may not be applicable for other types of cancer.
- −Technology Adoption: Requires clinicians to be adept at integrating new technologies into their practice.
- −Accessibility: Could be limited by the need for specific technological infrastructure to fully utilize the AI capabilities.
Limitations & when to consider alternatives
Known limitations
- Clinician ordering is required. Patients cannot order the test directly; ordering is limited to qualified clinicians.
- The test is intended for localized prostate cancer. Artera positions the prostate test for risk-based decisions in localized prostate cancer.
- Results depend on specimen receipt. The stated 1–2 day turnaround begins after Artera receives the patient’s specimen.
- Coverage varies by insurance. Patient financial responsibility depends on insurance benefits, deductibles, copays, and coinsurance.
- The breast test is not available for ordering in New York. Artera states that the ArteraAI Breast Cancer Test is available in 49 states, excluding New York.
Look elsewhere when
- You need a self-service patient-ordering tool.
- You need a general-purpose AI assistant or coding tool.
- You need a documented developer API.
How to Use Artera
- 1
Explore the extensive range of tutorials available on the Artera website, covering everything from basic operation to advanced features of the ArteraAI Prostate Test.
Who is Artera For?
Clinicians
Clinicians use the test to support risk-based treatment decisions for localized prostate cancer.
Patients with localized prostate cancer
Patients can discuss the test with their doctor to help inform treatment and active-surveillance decisions.
Patients considering post-surgery treatment
The test is available after surgery when PSA rises and additional treatment is being considered.
Frequently Asked Questions
Who can order the ArteraAI Prostate Test?
Ordering is limited to clinicians whose license and scope of practice allow them to order the test.
Can patients order the test themselves?
No. Patients should discuss the test with their doctor, who can determine whether it is appropriate.
How quickly are results available?
Results are typically ready within 1–2 days after the specimen reaches Artera’s CLIA-certified laboratory.
What information does the test use?
The test uses digitized biopsy-slide images and patient clinical information.
How are reports delivered?
Clinicians can access reports through an online portal or receive them by fax.
Is the test covered by insurance?
Coverage and out-of-pocket responsibility depend on the patient’s insurance plan. Artera also offers financial assistance.
Community reviews
Be the first to share your experience.
Sign in to leave a review for Artera.
Artera Alternatives
Looking for alternatives to Artera? Here are similar tools in the same category:
Learn to Master Artera
With Skill Leap courses
Get in-depth training on Artera and 50+ other AI tools with our expert-led video courses.
Start 7-Day Free Trial